CPUH.U — Compute Health Acquisition Income Statement
0.000.00%
- $315.55m
- $318.38m
- 38
- 34
- 44
- 31
Annual income statement for Compute Health Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 0.005 | 2.27 | 4.69 |
| Operating Profit | -0.005 | -2.27 | -4.69 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.005 | 5.76 | 34.5 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.005 | 5.76 | 32.4 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.005 | 5.76 | 32.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | -0.005 | 5.76 | 32.4 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0 | 0.059 | 0.315 |
| Dividends per Share |